Home > Boards > US Listed > Biotechs > MediciNova, Inc. (MNOV)

$MNOV recent news/filings

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 463
Posts 9,969
Boards Moderated 2
Alias Born 04/28/14
160x600 placeholder
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary F... GlobeNewswire Inc. - 10/7/2019 7:00:00 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in ... GlobeNewswire Inc. - 9/30/2019 7:00:00 PM
MediciNova to Present at the Ladenburg Thalmann 2019 Healthcare Conference in New York GlobeNewswire Inc. - 9/11/2019 7:00:00 PM
MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York GlobeNewswire Inc. - 8/29/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 5:03:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/23/2019 5:02:32 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/23/2019 6:00:54 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/9/2019 5:03:28 PM
MediciNova Announces MN-001 Research Collaboration with the National Cerebral and Cardiovascular Disease Research Center in J... GlobeNewswire Inc. - 7/30/2019 7:00:00 PM
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND... GlobeNewswire Inc. - 7/29/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 6:05:48 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/25/2019 4:17:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/25/2019 11:27:05 AM
MediciNova Appoints Kazuko Matsuda to its Board of Directors GlobeNewswire Inc. - 7/24/2019 11:00:00 PM
MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS GlobeNewswire Inc. - 7/11/2019 7:00:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/21/2019 12:13:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:07:04 PM
MediciNova to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:15:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:05:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:03:53 PM
MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS GlobeNewswire Inc. - 6/5/2019 7:00:00 PM
MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire Inc. - 5/15/2019 7:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:42:49 PM
stocktrademan   Monday, 12/14/15 11:39:14 AM
Re: None
Post # of 392 
$MNOV recent news/filings

bullish 3.532
inverted head and shoulders
moving average breakout

## source: finance.yahoo.com

Mon, 14 Dec 2015 08:59:00 GMT ~ 3:59 am MediciNova reports positive interim safety and clinical outcomes data from clinical trial of MN-166


read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#mnov
*********************************************************

Sun, 13 Dec 2015 23:10:08 GMT ~ MediciNova Announces Positive Interim Safety and Clinical Outcomes Data From Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 26th International Symposium on ALS/MND in Orlando, FL

[at noodls] - , (GLOBE NEWSWIRE) -- , a biopharmaceutical company traded on the (NASDAQ:MNOV) and the JASDAQ Market of the (Code Number:4875), announced that principal investigator Dr. , Director, Neuromuscular/ALS-MDA ...

read full: http://www.noodls.com/view/058AA174BC313F7BD0D383FC78954FB6C16B8524
*********************************************************

Sun, 13 Dec 2015 23:00:00 GMT ~ MediciNova Announces Positive Interim Safety and Clinical Outcomes Data From Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 26th International Symposium on ALS/MND in Orlando, FL

[GlobeNewswire] - LA JOLLA, Calif., Dec. 13, 2015-- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that principal investigator ...

read full: http://finance.yahoo.com/news/medicinova-announces-positive-interim-safety-230000214.html
*********************************************************

Wed, 09 Dec 2015 22:44:03 GMT ~ MediciNova Announces Positive Findings From a Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder (AUD) Reported at the American College of Neuropsychopharmacology (ACNP)'s 54th Annual Meeting

[at noodls] - MediciNova Announces Positive Findings From a Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder (AUD) Reported at the American College of Neuropsychopharmacology (ACNP)'s 54th Annual Meeting...

read full: http://www.noodls.com/view/6DB43E3D7B5CD8C01DCA3964BF96FB2673C95EFF
*********************************************************

Wed, 09 Dec 2015 22:30:00 GMT ~ MediciNova Announces Positive Findings From a Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder (AUD) Reported at the American College of Neuropsychopharmacology (ACNP)'s 54th Annual Meeting

[GlobeNewswire] - LA JOLLA, Calif., Dec. 09, 2015-- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that Dr. Daniel Roche today ...

read full: http://finance.yahoo.com/news/medicinova-announces-positive-findings-clinical-223000485.html
*********************************************************

$MNOV charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$MNOV company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/MNOV/company-info
Ticker: $MNOV
OTC Market Place: Not Available
CIK code: 0001226616
Company name: Medicinova, Inc.
Incorporated In: DE, USA

Business Description:

$MNOV share structure

## source: otcmarkets.com

Market Value: $104,248,603 a/o Dec 11, 2015
Shares Outstanding: 29,956,495 a/o Oct 23, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001

$MNOV extra dd links

Company name: Medicinova, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MNOV+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MNOV+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MNOV+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MNOV/news - http://finance.yahoo.com/q/h?s=MNOV+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MNOV/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MNOV/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MNOV+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MNOV
DTCC (dtcc.com): http://search2.dtcc.com/?q=Medicinova%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Medicinova%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Medicinova%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MNOV
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001226616&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MNOV/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MNOV/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MNOV&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MNOV
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MNOV/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MNOV+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MNOV+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MNOV
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MNOV
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MNOV+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MNOV/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MNOV+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MNOV.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MNOV
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MNOV/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MNOV/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MNOV
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MNOV
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MNOV:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MNOV
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MNOV



$MNOV DD Notes ~ http://www.ddnotesmaker.com/MNOV

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist